Search

Displaying results 1911 - 1920 of 10000 in total
  1. Drug

    ATG-101

    go.drugbank.com/drugs/DB17162
    Investigational

    ATG-101 is a novel PD-L1/4-1BB bispecific antibody that was designed to block the binding of immunosuppressive PD-1/PD-L1 and conditionally induce 4-1BB stimulation, thus activating anti-tumor immune effectors

    Synonyms: PD-L1/4-1BB bispecific antibody
  2. Drug

    FBX-101

    go.drugbank.com/drugs/DB18340
    Investigational

    FBX-101 is an adeno-associated virus serotype rhesus 10 vector expressing the human galactocerebrosidase (GALC) gene

  3. Drug

    T-2000

    go.drugbank.com/drugs/DB11654
    Investigational

    T2000 has been used in trials studying the treatment of Myoclonus and Essential Tremor.

  4. Drug

    BN-201

    go.drugbank.com/drugs/DB18295
    Investigational

  5. Drug

    NCX-1000

    go.drugbank.com/drugs/DB16026
    Investigational

    NCX-1000 is under investigation in clinical trial NCT00414869 (Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure).

  6. Drug

    TZP-102

    go.drugbank.com/drugs/DB16129
    Investigational

    TZP-102 is under investigation in clinical trial NCT01452815 (Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis).

  7. Drug

    Ilaprazole

    go.drugbank.com/drugs/DB11964
    Investigational

    Ilaprazole has been investigated in Helicobacter Infections.

    Products: NOLTEC 10 MG GASTRO-REZİSTAN TABLET, 7 ADET, NOLTEC 10 MG GASTRO-REZİSTAN TABLET, 28 ADET
  8. Drug

    AIM-102

    go.drugbank.com/drugs/DB16176
    Investigational

    AIM-102 is under investigation in clinical trial NCT01501942 (Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic

  9. Drug

    ATL-104

    go.drugbank.com/drugs/DB05670
    Investigational

    ATL-104 is a potent mitogen for epithelial cells of the gastrointestinal tract. In animal models, ATL-104 aids regeneration of the gastrointestinal tract after treatment with chemotherapeutic agents.

  10. Drug

    RTL-1000

    go.drugbank.com/drugs/DB17946
    Investigational

    RTL-1000 is a recombinant T-Cell receptor ligand being investigated for the treatment of multiple sclerosis.

    Synonyms: Recombinant t-cell receptor ligand rtl-1000, Rtl-1000 (recombinant t-cell receptor ligand)